|
1.
|
Bielack S, Kempf-Bielack B, Delling G,
Exner G, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M,
Winkelmann W, Zoubek A, Jürgens H and Winkler K: Prognostic factors
in high-grade osteosarcoma of the extremities or trunk: an analysis
of 1702 patients treated on neoadjuvant cooperative osteosarcoma
study group protocols. J Clin Oncol. 20:776–790. 2002. View Article : Google Scholar
|
|
2.
|
Davis AM, Bell RS and Goodwin PJ:
Prognostic factors in osteosarcoma: a critical review. J Clin
Oncol. 12:423–431. 1994.PubMed/NCBI
|
|
3.
|
Baldini N, Scotlandi K, Barbanti-Brodano
G, Manara M, Maurici D, Bacci G, Bertoni F, Picci P, Sottili S and
Campanacci M: Expression of P-glycoprotein in high-grade
osteosarcomas in relation to clinical outcome. N Engl J Med.
333:1380–1385. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Ferrari S, Bertoni F, Zanella L, Setola E,
Bacchini P, Alberghini M, Versari M and Bacci G: Evaluation of
p-glycoprotein, HER2/ErbB-2, p53, and bcl-2 in primary tumor and
metachronous lung metastases in patients with high-grade
osteosarcoma. Cancer. 100:1936–1942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Pakos E and Ioannidis J: The association
of p-glycoprotein with response to chemotherapy and clinical
outcome in patients with osteosarcoma. A meta-analysis Cancer.
98:581–589. 2003.PubMed/NCBI
|
|
6.
|
Sulzbacher I, Birner P, Trieb K, Traxler
M, Lang S and Chott A: Expression of platelet-derived growth
factor-AA is associated with tumor progression in osteosarcoma. Mod
Pathol. 16:66–71. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Trieb K and Kotz R: Proteins expressed in
osteosarcoma and serum levels as prognostic factors. Int J Biochem
Cell Biol. 33:11–17. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Chao D and Korsmeyer S: Bcl-2 family:
regulators of cell death. Ann Rev Immunol. 16:395–419. 1998.
View Article : Google Scholar
|
|
9.
|
Jäättelä M: Escaping cell death: survival
proteins in cancer. Exp Cell Res. 248:30–43. 1999.PubMed/NCBI
|
|
10.
|
Amling M, Pösl M, Bälser I and Delling G:
Osteosarcoma - apoptosis and proliferation. Pathologe. 15:337–344.
1994.(In German).
|
|
11.
|
Wang ZX, Yang JS, Pan X, Wang JR, Li J,
Yin YM and De W: Functional and biological analysis of Bcl-xL
expression in human osteosarcoma. Bone. 47:445–454. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Wu X, Cai ZD, Lou LM and Zhu YB:
Expression of p53, BCL-2, and apoptotic index in human osteosarcoma
and their correlation with prognosis of patients. Cancer Epidemiol.
36:212–216. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Kaseta MK, Khaldi L, Gomatos IP,
Tzagarakis GP, Alevizos L, Leandros E, Papagelopoulos PJ and
Soucacos PN: Prognostic value of bax, cytochrome C, and caspase-8
protein expression in primary osteosarcoma. J Surg Oncol.
97:259–266. 2008.
|
|
14.
|
Nedelcu T, Kubista B, Koller A, Sulzbacher
I, Mosberger I, Arrich F, Trieb K, Kotz R and Toma CD: Livin and
Bcl-2 expression in high-grade osteosarcoma. J Canc Res Clin Oncol.
134:237–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Enneking WF, Spanier SS and Goodman MA: A
system for the surgical staging of musculoskeletal sarcoma. Clin
Orthop. 153:106–120. 1980.PubMed/NCBI
|
|
16.
|
Salzer-Kuntschik M, Brand G and Delling G:
Determination of the degree of morphological regression following
chemotherapy in malignant bone tumors. Pathologe. 4:135–141.
1983.(In German).
|
|
17.
|
Bankfalvi A, Navabi H, Bier P, Böcker W,
Jansani B and Schmid K: Wet autoclave pretreatment for antigen
retrieval in diagnostic immunohistochemistry. J Pathol.
174:223–229. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kaplan E and Meier P: Nonparametic
estimation from incomplete observations. J Am Stat Assoc.
53:457–461. 1958. View Article : Google Scholar
|
